Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivity.

We treated a patient with severe myasthenia gravis with a chimeric (murine/human) anti-CD4 monoclonal antibody (cM-T412) for 7 days and followed the therapeutic effect by standardized muscle function tests, single-fiber electromyography, and immunologic examinations of disease-specific B- and T-cell functions. Clinical and electrophysiologic improvement began within 4 days, lasted for 3 months, and was maximal between days 16 and 58. The CD4+ lymphocytes decreased to a minimum of 80 cells per microliters of peripheral blood, recovered slowly during the first year of follow-up, and did not correlate with changes in disease severity. T-cell stimulation by human acetylcholine receptor was abolished by the treatment but became detectable at the time of worsening of symptoms. The concentration of acetylcholine receptor antibodies in serum was not decreased by the treatment. The results suggest that anti-CD4 antibody administration could be effective in the treatment of severe myasthenia gravis and indicate that acetylcholine receptor-specific T lymphocytes might contribute to the disturbed neuromuscular transmission in the disease.
AuthorsR Ahlberg, Q Yi, R Pirskanen, G Matell, C Swerup, E P Rieber, G Riethmüller, G Holm, A K Lefvert
JournalNeurology (Neurology) Vol. 44 Issue 9 Pg. 1732-7 (Sep 1994) ISSN: 0028-3878 [Print] UNITED STATES
PMID7936306 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Antibodies, Monoclonal
  • Antigens, CD4
  • Receptors, Cholinergic
  • Antibodies (analysis)
  • Antibodies, Monoclonal (therapeutic use)
  • Antigens, CD4
  • Female
  • Humans
  • Immunotherapy
  • Middle Aged
  • Myasthenia Gravis (immunology, therapy)
  • Receptors, Cholinergic (immunology)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: